In vitro emergence of fluoroquinolone resistance in Cutibacterium (formerly Propionibacterium) acnes and molecular characterization of mutations in the gyrA gene. (October 2017)

• Record Type: Journal Article
• Authors: Takoudju, Eve-Marie; Guillouzouic, Aurélie; Kambarev, Stanimir; Pecorari, Frédéric; Corvec, Stéphane
• Is Part Of: Anaerobe. Volume 47(2017)
• Page Start: 194
• Page End: 200
• Publication Date: 2017-10
• Subjects: Cutibacterium acnes -- Foreign-body infection -- Fluoroquinolone -- Resistance -- Biofilm; Anaerobic infections -- Periodicals; Anaerobic bacteria -- Periodicals; Bacterial diseases -- Periodicals; Computer network resources; Anaerobic protozoa -- Periodicals; 579.3
• DOI: 10.1016/j.anaerobe.2017.06.005
• Languages: English
• ISSNs: 1075-9964

Abstract

Abstract: In vitro occurrence of levofloxacin (LVX) resistance in C. acnes and characterization of its molecular background were investigated. The mutation frequency was determined by inoculation of 10 8 cfu of C. acnes ATCC 11827 (LVX MIC = 0.25 mg/L) on LVX-containing agar plates. The progressive emergence of resistance was studied by a second exposure to increasing LVX concentrations. For mutants, the QRDR regions including the gyrA and parC genes were sequenced and compared to both C. acnes ATCC 11827 and C. acnes KPA171202 reference sequences (NC006085). The importance of the efflux pump system in resistance was investigated by using inhibitors on selected resistant mutants with no mutation in the QRDR. C. acnes growth was observed on LVX-containing plates with mutation frequencies of 3. 8 cfu × 10 −8 (8 × MIC) and 1.6 cfu × 10 −7 (4 × MIC). LVX resistance emerged progressively after one-step or two-step assays. In LVX-resistant isolates, the MIC ranged from 0.75 to >32 mg/L. Mutations were detected exclusively in the gyrA gene. Ten genotypes were identified: G99 C, G99 D, D100N, D100 H, D100 G, S101L, S101W, A102 P, D105 H and A105 G. Mutants S101L and S101W were always associated with a high level of resistance. Mutants with no mutation in the QRDR were more susceptible when incubated with an efflux pump inhibitor (phenyl-arginine β-naphthylamide) only, suggesting, for the first time, the expression of such a system in C. acnes LVX-resistant mutants. Highlights: Levofloxacin-resistant Cutibacterium acnes mutants can be easily selected in vitro . Low- and high-levels resistance can be observed. Only GyrA amino-acid changes lead to levofloxacin-resistance. S101L substitution is the most frequent one detected with high-level resistance to levofloxacine MIC>32 mg/L. Mutants without any mutation may express efflux pump system.